Department of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
RIKEN, Center for Integrative Medical Sciences, Suehiro-cho, Tsurumi, Yokohama, Japan.
J Biol Chem. 2020 Jun 19;295(25):8560-8574. doi: 10.1074/jbc.RA119.012280. Epub 2020 May 6.
Epidermal growth factor (EGF) domain-specific -GlcNAc transferase (EOGT) is an endoplasmic reticulum (ER)-resident protein that modifies EGF repeats of Notch receptors and thereby regulates Delta-like ligand-mediated Notch signaling. Several mutations that may affect putative -glycosylation consensus sites are recorded in the cancer database, but the presence and function of -glycans in EOGT have not yet been characterized. Here, we identified -glycosylation sites in mouse EOGT and elucidated their molecular functions. Three predicted -glycosylation consensus sequences on EOGT are highly conserved among mammalian species. Within these sites, we found that Asn-263 and Asn-354, but not Asn-493, are modified with -glycans. Lectin blotting, endoglycosidase H digestion, and MS analysis revealed that both residues are modified with oligomannose -glycans. Loss of an individual -glycan on EOGT did not affect its endoplasmic reticulum (ER) localization, enzyme activity, and ability to -GlcNAcylate Notch1 in HEK293T cells. However, simultaneous substitution of both -glycosylation sites affected both EOGT maturation and expression levels without an apparent change in enzymatic activity, suggesting that -glycosylation at a single site is sufficient for EOGT maturation and expression. Accordingly, a decrease in -GlcNAc stoichiometry was observed in Notch1 co-expressed with an N263Q/N354Q variant compared with WT EOGT. Moreover, the N263Q/N354Q variant exhibited altered subcellular distribution within the ER in HEK293T cells, indicating that -glycosylation of EOGT is required for its ER localization at the cell periphery. These results suggest critical roles of -glycans in sustaining -GlcNAc transferase function both by maintaining EOGT levels and by ensuring its proper subcellular localization in the ER.
表皮生长因子 (EGF) 结构域特异性 -GlcNAc 转移酶 (EOGT) 是一种内质网 (ER) 驻留蛋白,可修饰 Notch 受体的 EGF 重复序列,从而调节 Delta 样配体介导的 Notch 信号。癌症数据库中记录了几个可能影响推定的 -糖基化共识位点的突变,但 EOGT 中的 -聚糖的存在和功能尚未得到表征。在这里,我们鉴定了小鼠 EOGT 中的 -糖基化位点,并阐明了它们的分子功能。在哺乳动物物种中,EOGT 上的三个预测的 -糖基化共识序列高度保守。在这些位点内,我们发现天冬酰胺-263 和天冬酰胺-354 被 -聚糖修饰,但天冬酰胺-493 没有被修饰。凝集素印迹、内切糖苷酶 H 消化和 MS 分析表明,这两个残基都被寡甘露糖 -聚糖修饰。EOGT 上单个 -聚糖的缺失不影响其内质网 (ER) 定位、酶活性以及在 HEK293T 细胞中对 Notch1 的 -GlcNAc 化。然而,两个 -糖基化位点的同时取代会影响 EOGT 的成熟和表达水平,而酶活性没有明显变化,这表明单个位点的 -糖基化足以使 EOGT 成熟和表达。因此,与 WT EOGT 相比,与 Notch1 共表达时,观察到 -GlcNAc 化学计量减少。此外,与 WT EOGT 相比,N263Q/N354Q 变体在 HEK293T 细胞中在内质网内的亚细胞分布发生改变,表明 EOGT 的 -糖基化对于其在细胞边缘的 ER 定位是必需的。这些结果表明,-聚糖通过维持 EOGT 水平和确保其在 ER 中的适当亚细胞定位,在维持 -GlcNAc 转移酶功能方面发挥着关键作用。